JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

polyneuropathy

Onpattro (patisiran): the first RNAi therapeutic approved in the European Union

Posted: January 30, 2019

|

Categories: Approvals

|

Tags: polyneuropathy , patisiran , onpattro , amyloidosis

|

Author: Joanna Bankersingh

Onpattro (patisiran) is a first-in-class treatment that slows down the progression of hereditary transthyretin amyloidosis (hATTR).

Read more »